Finally, the main limitation of the PSA+DRE diagnostic procedure is the inability to distinguish clinically significant cancers (pathologic stage, tumor volume, and cancer grade) from non-life-threatening tumor lesions in the prostate. The gene discussed is KLK3; the disease is cancer.